MBDB is a chemical compound of the amphetamine class. It has an empathogenic effect similar to that of MDMA . In contrast, MDMA does not show a significant psychostimulating effect. According to PiHKAL , the active dose of the substance is in the range of 180-210 mg.
| MBDB | |
|---|---|
 | |
 | |
| Are common | |
| Systematic name | 1- (1,3-benzodioxol-5-yl) -N-methylbutan-2-amine |
| Abbreviations | MBDB |
| Chem. formula | C₁₂H₁₇NO₂ |
| Rat formula | C 12 H 17 NO 2 |
| Physical properties | |
| Molar mass | 207.26888 g / mol |
| Thermal properties | |
| T. melt. | 156 ° C |
| Classification | |
| Reg. CAS number | |
| PubChem | |
| Smiles | |
| Inchi | |
| ChemSpider | |
Legal Status
MBDB is not subject to international control under the Convention on Psychotropic Substances , but in Russia it is listed in List I of the list of narcotic drugs, psychotropic substances and their precursors to be controlled.
See also
- Butylon (bk-MBDB)
- BDB
Literature
- A. Shulgin. PIHKaL: Methyl-J (English) (1991). Date of treatment November 28, 2009.
- Richard A. Glennon. Neurobiology of Hallucinogens // The American Psychiatric Publishing textbook of substance abuse treatment . - American Psychiatric Publishing, 2008 .-- S. 183-187. - 616 p. - ISBN 978-1-58562-276-4 .
- PubChem: CID 124844 (English) . Date of treatment November 28, 2009. Archived April 11, 2012.